Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
15.5M
-
Shares change
-
-719K
-
Total reported value, excl. options
-
$213M
-
Value change
-
-$11.2M
-
Put/Call ratio
-
2.67
-
Number of buys
-
50
-
Number of sells
-
-62
-
Price
-
$13.69
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2017
172 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2017.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.5M shares
of 54.8M outstanding shares and own 28.37% of the company stock.
Largest 10 shareholders include STATE STREET CORP (3.61M shares), BlackRock Inc. (1.76M shares), VANGUARD GROUP INC (1.18M shares), FMR LLC (1.16M shares), Chescapmanager LLC (1.02M shares), DISCIPLINED GROWTH INVESTORS INC /MN (849K shares), PRICE T ROWE ASSOCIATES INC /MD/ (456K shares), FRANKLIN RESOURCES INC (435K shares), JPMORGAN CHASE & CO (360K shares), and NORTHERN TRUST CORP (328K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.